SAB Biotherapeutics reported cash from operations of -$9.84M and free cash flow of -$11.43M for the quarter ended Jun 2026, down 37.6% year over year. This cash flow statement covers 23 quarters of results from Dec 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||||||
| Net Income | -4.06M | -11.55M | 0.99M | -4.78M | -7.08M | -7.85M | -7.35M | -6.88M | -5.10M | -22.86M | -5.03M | -7.34M | -10.35M | -9.94M | -10.78M | -9.78M | -12.07M | -15.13M | -19.01M | -21.73M | |||
| Share-based Compensation | 0.88M | 0.65M | 5.56M | 5.29M | 7.45M | 0.63M | 9.60M | 9.94M | 9.82M | 1.99M | 2.07M | 1.89M | 3.10M | 0.67M | 2.96M | 2.94M | 11.80M | 2.79M | 38.96M | 92.80M | |||
| Gains from Investment Securities | -0.00M | 5.65M | -7.85M | -1.73M | -0.78M | -0.04M | -0.08M | 0.36M | -0.18M | 4.73M | -5.47M | -2.22M | -0.01M | 2.31M | -5.04M | 0.63M | -61.60M | 3.25M | 0.48M | 1.11M | |||
| Change in Interest Receivables | 0.19M | 0.03M | -0.13M | -0.04M | -0.03M | -0.02M | 0.56M | 0.39M | 0.61M | 0.29M | |||||||||||||
| Cash from Operations | 3.80M | -4.88M | -9.54M | -4.45M | -7.92M | -1.56M | -1.61M | -4.90M | -5.17M | -13.45M | -10.75M | -7.72M | -6.29M | -9.53M | -7.80M | -7.15M | -13.05M | -16.78M | -14.27M | -9.84M | |||
| Depreciation, Depletion & Amortization | |||||||||||||||||||||||
| Amortizatization of Intangibles | 0.04M | 0.04M | 0.04M | 0.03M | 0.02M | 0.02M | 0.03M | 0.02M | 0.02M | 0.03M | 0.08M | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M | 0.03M | 0.02M | 0.02M | |||
| Amortization of Deferred Charges | 0.04M | 0.04M | 0.04M | 0.03M | 0.02M | ||||||||||||||||||
| Depreciation & Amortization (CF)Depreciation & Amortization | 0.37M | 0.62M | 0.64M | 0.75M | 0.89M | 0.93M | 0.90M | 0.90M | 1.00M | 0.97M | 2.00M | 1.00M | 0.90M | 0.76M | 0.80M | 0.80M | 0.70M | 0.70M | 0.73M | 0.80M | |||
| Change in Working Capital | |||||||||||||||||||||||
| Change in Receivables | -6.90M | -2.20M | 3.78M | -2.17M | 3.33M | -7.39M | -4.79M | -0.40M | -0.36M | ||||||||||||||
| Change in Account Payables | -1.40M | 0.34M | 0.52M | -0.04M | 0.54M | -1.81M | -2.23M | -0.04M | -0.32M | -0.11M | 0.24M | -0.05M | 0.13M | 0.59M | 0.68M | 0.14M | 0.34M | 0.32M | 0.11M | 0.67M | |||
| Change in Accured Expenses | 1.58M | 0.28M | -0.60M | -2.00M | 0.38M | -0.32M | -1.73M | -0.76M | -0.63M | 1.40M | -1.58M | -0.07M | 1.86M | -1.44M | 0.58M | 1.04M | -0.29M | -0.39M | -1.19M | 1.83M | |||
| Change in Taxes | 0.09M | ||||||||||||||||||||||
| Other Working Capital Changes | -0.10M | 2.94M | -0.04M | -1.27M | -0.31M | -0.94M | -0.26M | -0.11M | 0.29M | 0.26M | -2.13M | 6.86M | 0.30M | -1.19M | |||||||||
| Investing Activities | |||||||||||||||||||||||
| Capital Expenditures | 3.23M | 2.36M | 1.36M | 0.61M | 0.08M | 0.12M | 0.02M | 0.02M | 0.09M | 0.07M | 0.13M | 0.05M | 0.10M | 0.06M | 0.98M | 1.59M | |||||||
| Sales of Property, Plant and Equipment | 0.08M | 0.04M | 500.00 | 500.00 | -500.00 | 0.00M | 783.00 | ||||||||||||||||
| Change in Acquisitions & Divestments | 3.75M | 10.69M | 4.74M | 5.25M | 364.00 | 11.27M | 74.60M | 9.71M | |||||||||||||||
| Cash from Investing Activities | -3.23M | -2.36M | -1.28M | -0.61M | -0.08M | -0.12M | -0.02M | -0.02M | -0.04M | -0.07M | -31.36M | 11.22M | -1.15M | 9.33M | 4.67M | 5.20M | -129.87M | -1.71M | -65.65M | -4.88M | |||
| Financing Activities | |||||||||||||||||||||||
| Other financing activities | -4.17M | 0.01M | 0.07M | 1.00 | -1.00 | 0.00M | 0.00M | 59.65M | 0.02M | -3.00 | 2.98M | 0.54M | |||||||||||
| Debt Issuance and Repayment | |||||||||||||||||||||||
| Long-Term Debt Issuances | 2.69M | 0.76M | 0.76M | 0.25M | 3.75M | 0.33M | 0.33M | 0.11M | 0.26M | 0.22M | 0.22M | 0.62M | 0.24M | 0.14M | 0.14M | 3.00 | |||||||
| Change in Capital Stock | |||||||||||||||||||||||
| Net Shares Issued and Repurchased | 1.35M | 0.49M | 2.93M | 2.55M | 0.38M | 1.08M | 2.43M | 0.01M | 18.19M | 18.64M | |||||||||||||
| Net Equity Issued and Repurchased | |||||||||||||||||||||||
| Misc. | |||||||||||||||||||||||
| Cash from Financing Activities | -0.05M | 36.03M | -6.32M | -0.73M | -0.29M | 8.39M | -0.36M | -0.36M | -0.14M | 67.64M | -0.39M | -0.32M | -0.67M | 0.22M | -0.17M | -0.17M | 168.69M | -0.04M | 89.92M | 2.36M | |||
| Exchange Rate Effect | -0.03M | 0.03M | 0.05M | -0.29M | 0.04M | 0.18M | -0.04M | -0.40M | 0.01M | 0.11M | |||||||||||||
| Change in Cash | 0.52M | 28.79M | -17.14M | -5.79M | -8.28M | 6.71M | -1.99M | -5.29M | -5.35M | 54.14M | -42.53M | 3.21M | -8.07M | -0.27M | -3.26M | -1.95M | 25.73M | -18.92M | 10.02M | -12.25M | |||
| Free Cash Flow | 0.57M | -7.24M | -10.90M | -5.06M | -8.00M | -1.67M | -1.63M | -4.92M | -5.25M | -13.51M | -10.88M | -7.77M | -6.39M | -9.59M | -7.80M | -7.15M | -13.05M | -16.78M | -15.25M | -11.43M | |||
| Net Cash Flow | 0.52M | 28.79M | -17.14M | -5.79M | -8.28M | 6.71M | -1.99M | -5.29M | -5.35M | 54.12M | -42.50M | 3.18M | -8.12M | 0.02M | -3.30M | -2.13M | 25.77M | -18.52M | 10.00M | -12.36M |